Glossary
October 14, 2026

Researchers Use AI to Read Thousands of Online Posts About an Unapproved Weight-Loss Drug, and Find Side Effects the Drug Trials Didn't Highlight

Thousands of people are buying an experimental weight-loss drug online before it has been approved. Researchers at the University of Pennsylvania used an AI program to read nearly 150,000 of their posts on Reddit and found the most common complaint was the opposite of what the drug is meant to do: feeling hungrier. It is an early warning, not proof, and a glimpse of how AI can help spot drug problems sooner.

A team at the University of Pennsylvania published a study today in the medical journal JAMA Network Open about retatrutide, an experimental weight-loss drug in the same family as Ozempic. Retatrutide is still being tested and has not been approved by the U.S. Food and Drug Administration, but people are buying versions of it online anyway and talking about their experiences on Reddit, a popular discussion website.

No person could read all of those conversations, so the researchers had an AI program do it. They collected 148,640 posts and comments from 27 Reddit groups about the drug, peptides and weight loss, written between May 2021 and December 2025. The AI program picked out people who said they were taking the drug themselves, then pulled out the symptoms they described and sorted them into the standard terms doctors use to report side effects. The team checked a sample of 100 posts by hand and found the program did this accurately.

The AI found 13,589 people who said they were taking retatrutide, and 7,823 of them described at least one symptom. The most common was increased appetite, mentioned by about 17 percent, which is surprising for a drug meant to curb hunger. Tiredness, a burst of energy, nausea, food cravings, trouble sleeping and a faster heartbeat were also common. In the official drug trials so far, the side effects reported most often were stomach problems like nausea. Compared with the team's earlier look at Reddit posts about Ozempic and similar drugs, people on retatrutide talked more about appetite, sleep, energy, muscles and heart rate.

The researchers are careful to say these are clues, not proven side effects. They can't check what was really in the vials people bought online, how much they took, what else they were taking, or whether the drug caused any given symptom. People who buy unapproved drugs online may also be different from the patients in a clinical trial. The authors say the findings are a starting point for proper studies, and that the AI program can miss or mislabel symptoms.

The bigger idea is a new kind of early warning. Drug safety problems usually surface slowly, through doctors' reports and trials. Here, an AI program read years of everyday conversation in a short time and pointed to questions worth asking, while the drug is still being tested.

Sources

  1. JAMA Network Open — Self-reported adverse effects among social media users taking nonapproved retatrutide (research letter)jamanetwork.com · primary
  2. ScienceDaily — University of Pennsylvania release on the AI analysis of retatrutide postssciencedaily.com
Follow the timeline
Get an email when new entries are added.
© 2026 Sugarpine